Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coenzyme Q10 in the Amelioration of Cognitive Deficits and Symptoms in Schizophrenia and Schizoaffective Disorder

NCT03576911 is registered in ClinicalTrials.gov with University of Dublin, Trinity College as lead sponsor.

NCT NCT03576911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03576911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coenzyme Q10 in the Amelioration of Cognitive Deficits and Symptoms in Schizophrenia and Schizoaffective Disorder
Lead sponsor
University of Dublin, Trinity College
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
August 31, 2019
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia